Growth hormone–secreting pituitary adenoma (GHPA) accounts for 12.5% of pituitary neuroendocrine tumors, and excessive growth hormone results in acromegaly and systemic complications [1]. This evidence concerns the gene GH1 and pituitary gland adenoma.